Call for Abstract

6th Global Experts Meeting on Cardiovascular Pharmacology, will be organized around the theme “Advancing into the Future of Heart Science and Pharmacology Medicine”

Cardiac Pharmacology 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cardiac Pharmacology 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

\r\n Cardiovascular toxicology may be caused due to chemotherapy or due to the medication for the treatment of heart diseases. Cardiovascular Pharmacology deals with the study of drug action which exerts a biochemical or physiological effect on the tissue, cell, organ or organism. The interactions affect normal or abnormal biochemical function. The cardiovascular group is studying the connections between salt intake or obesity on blood pressure control mechanisms. These investigators use state of the art molecular, cellular and integrative approaches to study the vascular function and neural control of blood pressure.

  • Track 1-1Neurotoxicology
  • Track 1-2Drug addiction and alcohol dependence
  • Track 1-3Neurodegenerative disorders
  • Track 1-4Circadian rhythm disorders

\r\n Heart attack mistakenly refers to cardiac arrest, but heart attacks are caused by a blockage that stops the blood supply to the heart. This is because a person who is having a heart attack may develop a dangerous heart rhythm, which can cause a cardiac arrest. Cardiac arrest refers to the disruption of heart function that is the malfunction of an electrical system of the heart. This analysis demonstrates that the annual NIH investment in CA research is low relative to other leading causes of death in the United States and has declined over the past decade. Many cardiac arrests in adults happen because of a heart attack. Sudden cardiac death (SCD) from cardiac arrest is a major international public health problem accounting for an estimated 15–20% of all deaths; it is a leading cause of death in the United States.

  • Track 2-1Hypertrophic cardiomyopathy
  • Track 2-2Methamphetamine
  • Track 2-3Sudden cardiac arrest
  • Track 2-4Implantable cardiac defibrillator
  • Track 3-1Development of Pacemaking and Cardiac Conduction System lineages
  • Track 3-2Role of platelets and antiplatelet therapy in cardiovascular disease
  • Track 3-3Molecular targets of antihypertensive drug therapy
  • Track 3-4Personalized medicine in cardiology
  • Track 3-5Real-world evidence and outcomes research

\ General anaesthesia for cardiac MRI is governed by similar principles for any anaesthetic technique in children with heart disease. High-risk imaging refers to imaging in patients with medical or health-related risks, imaging with equipment-related risks, and procedure-related risks such as MRI-guided surgery, minimally invasive procedures. MRI can be performed in patients who have undergone previous cardiac surgery. Absolute contraindications include patients with pacemakers and defibrillators.  A Deep sedation or general anaesthesia is indicated in neonates, infants and small children for MRI. The challenges during MRI include limited access to patient and equipment, low ambient temperature with risk for hypothermia and a noisy unfamiliar environment with the remote location from the operating room. Anaesthetic care for magnetic resonance imaging (MRI) as moderate sedation, deep sedation, monitored anaesthesia care, general anaesthesia, or ventilatory and critical care support.

  • Track 4-1Morphology
  • Track 4-2Cardiac MR imaging
  • Track 4-3Neurological effects
  • Track 4-4CT radiation risk

\ A heart transplant is a treatment that's usually reserved for people this is a treatment option for people who are in the end stages of heart failure, but their conditions haven't sufficiently improved. 90% of heart transplants are performed on patients with end-stage heart failure. A heart transplant is an operation in which the diseased heart in a person is replaced with a healthy heart from a deceased donor. The first heart transplant patient survived only 18 days, four of Groote Schuur Hospital’s first 10 patients survived for more than one year, two living for 13 and 23 years, respectively. Clinical research studies are designed to answer specific questions, sometimes about a new drug or medical device's safety and effectiveness. Rejection is the most common cause of the donor's heart failing in heart transplant patients. If the transplanted heart fails, the patient dies.

  • Track 5-1heart failure
  • Track 5-2Coronary heart disease
  • Track 5-3Pulmonary hypertension
  • Track 5-4Organ Procurement and Transplantation Network
  • Track 5-5Donor Heart

\ Continuous subcutaneous insulin infusion (CSII) using an external pump, offers both a better blood glucose stability as compared to multiple daily injections and a broader flexibility in life mode and reduces the frequency of severe hypoglycemia. An insulin pump is a small device about the size of a small cell phone that is worn externally and can be discreetly clipped to your belt, slipped into a pocket, or hidden under your clothes. Advances in technology have allowed individuals with diabetes a choice in insulin delivery methods: MDI or CSII. Insulin pump therapy is an increasingly popular method of insulin replacement therapy. Because the insulin delivery from insulin pumps can more closely mimic what your body does naturally, you can improve your blood sugar control.

  • Track 6-1Genetic link of Diabetes
  • Track 6-2Obesity and Heart
  • Track 6-3Obesity & Cancer
  • Track 6-4Glucose Monitoring
  • Track 6-5Hypoglycemia

\ Cardiac surgery, or cardiovascular surgery, is surgery performed on the heart or blood vessels by cardiac surgeons. It is often used to treat complications of ischemic heart diseases like coronary artery bypass grafting, to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditisrheumatic heart disease, and atherosclerosis. It also includes heart transplantation.

  • Track 7-1Minimally invasive coronary artery bypass surgery
  • Track 7-2Valve-sparing aortic root replacement
  • Track 7-3Open heart surgery
  • Track 7-4Transmyocardial laser revascularization
  • Track 7-5Off-pump heart surgery

This chapter presents some preliminary findings and hypotheses drawn from field interviews with key participants who are involved in the innovation process in two important and widely used technologies that provide diagnostic information about the heart. It provides a forum for original and reviews articles related to experimental cardiology that meet its stringent scientific standards. Analysis of this  of the innovation process helped us to identify some points of leverage for increasing the rate and sharpening the focus of innovation. We discuss how these levers could productively stimulate changes in managerial and .  If much of what will transpire over the course of a day involves the use of various medical products, then what is needed are methods by which there can be a knowledge transfer (education) between the industry and . Much of the progress in cardiology during the 20th century was made possible by improved diagnostic tools.


  • Track 8-1Antibiotic Resistance
  • Track 8-2Clinical trials in Cardiology
  • Track 8-3Current Research in Cardiology
  • Track 8-4Cardiac and Cardiovascular Research
  • Track 9-1AIDS
  • Track 9-2Rabies
  • Track 9-3Water-borne illnesses
  • Track 9-4Vibrio vulnificus
  • Track 9-5Biostatistics
  • Track 9-6Public Health Sciences
  • Track 9-7Global Health

A healthy dietfight cardiovascular diseasephysical inactivitymethodologically sound evaluationsblood pressureDietary Approaches to Stop HypertensionTherapeutic Lifestyle Changesrisk factor for cardiovascular diseasepoor diet and other unhealthy habitsyears Exercise<span style="\&quot;color:" rgb(51,="" 51,="" 51);="" font-family:="" "helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" font-size:="" 14px;="" text-align:="" justify;="" background-color:="" rgb(255,="" 255,="" 255);\"=""> makes your heart stronger.


  • Track 15-1Alternative Medicine
  • Track 15-2Alcohol
  • Track 15-3Childhood and Adolescent Obesity
  • Track 15-4Fitness, Sports, and Sports Nutrition
  • Track 15-5Herbal Information & Heart Health

Childhood obesitynutritional disordernoncommunicable diseasescardiovascular diseasesblood cholesterolheart diseases in children and adultstype 2 diabetes<span style="\&quot;color:" rgb(51,="" 51,="" 51);="" font-family:="" "helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" font-size:="" 14px;="" text-align:="" justify;="" background-color:="" rgb(255,="" 255,="" 255);\"="">, hypertension, hyperlipidemia, liver and kidney diseases and causes reproductive dysfunction in adults.


  • Track 16-1Convenience foods and obesity
  • Track 16-2Weight Flux
  • Track 16-3Dyslipidemia
  • Track 16-4Hyperinsulinemia
  • Track 16-5Electrocardiography